JGP Global Gestao de Recursos’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $205K | Buy |
+8,110
| New | +$178K | 0.45% | 28 |
|
|
2026
Q1 | – | Sell |
-13,843
| Closed | -$370K | – | 29 |
|
|
2025
Q4 | $370K | Sell |
13,843
-9,239
| -40% | -$221K | 0.22% | 27 |
|
|
2025
Q3 | $493K | Sell |
23,082
-3,870
| -14% | -$91.5K | 0.29% | 9 |
|
|
2025
Q2 | $581K | Hold |
26,952
| – | – | 0.28% | 19 |
|
|
2025
Q1 | $448K | Sell |
26,952
-7,668
| -22% | -$139K | 0.34% | 14 |
|
|
2024
Q4 | $635K | Hold |
34,620
| – | – | 1.45% | 15 |
|
|
2024
Q3 | $532K | Sell |
34,620
-2,120
| -6% | -$35.4K | 1.04% | 17 |
|
|
2024
Q2 | $597K | Sell |
36,740
-15
| -0% | -$242 | 0.76% | 14 |
|
|
2024
Q1 | $680K | Buy |
36,755
+645
| +2% | +$16K | 0.44% | 19 |
|
|
2023
Q4 | $1.13M | Buy |
36,110
+19,757
| +121% | +$472K | 0.68% | 13 |
|
|
2023
Q3 | $341K | Sell |
16,353
-15
| -0.1% | -$407 | 0.22% | 30 |
|
|
2023
Q2 | $392K | Sell |
16,368
-12
| -0.1% | -$267 | 0.27% | 38 |
|
|
2023
Q1 | $308K | Sell |
16,380
-359
| -2% | -$6.84K | 0.32% | 38 |
|
|
2022
Q4 | $266K | Sell |
16,739
-4
| -0% | -$63 | 0.19% | 49 |
|
|
2022
Q3 | $274K | Buy |
16,743
+462
| +3% | +$7.48K | 0.23% | 42 |
|
|
2022
Q2 | $229K | Sell |
16,281
-9
| -0.1% | -$168 | 0.17% | 43 |
|
|
2022
Q1 | $395K | Sell |
16,290
-375
| -2% | -$9.07K | 0.23% | 37 |
|
|
2021
Q4 | $389K | Sell |
16,665
-3
| -0% | -$60 | 0.18% | 43 |
|
|
2021
Q3 | $277K | Sell |
16,668
-811
| -5% | -$15.6K | 0.1% | 61 |
|
|
2021
Q2 | $426K | Buy |
17,479
+7
| +0% | +$158 | 0.14% | 40 |
|
|
2021
Q1 | $451K | Buy |
+17,472
| New | +$769K | 0.28% | 27 |
|
|
2020
Q4 | – | Sell |
-22,916
| Closed | -$945K | – | 46 |
|
|
2020
Q3 | $945K | Buy |
22,916
+69
| +0.3% | +$2.98K | 0.52% | 21 |
|
|
2020
Q2 | $1.11M | Hold |
22,847
| – | – | 0.65% | 14 |
|
|
2020
Q1 | $965K | Buy |
22,847
+884
| +4% | +$36.4K | 0.42% | 25 |
|
|
2019
Q4 | $940K | Buy |
21,963
+167
| +0.8% | +$7.26K | 0.33% | 27 |
|
|
2019
Q3 | $784K | Buy |
21,796
+4,099
| +23% | +$124K | 0.43% | 23 |
|
|
2019
Q2 | $473K | Buy |
17,697
+8,494
| +92% | +$217K | 0.19% | 29 |
|
|
2019
Q1 | $247K | Buy |
+9,203
| New | +$215K | 0.09% | 53 |
|
|
2018
Q4 | – | Sell |
-12,825
| Closed | -$266K | – | 56 |
|
|
2018
Q3 | $266K | Buy |
+12,825
| New | +$202K | 0.45% | 19 |
|
|
2018
Q2 | – | Sell |
-12,273
| Closed | -$276K | – | 11 |
|
|
2018
Q1 | $276K | Hold |
12,273
| – | – | 0.11% | 16 |
|
|
2017
Q4 | $370K | Buy |
12,273
+666
| +6% | +$21.3K | 0.18% | 18 |
|
|
2017
Q3 | $437K | Buy |
+11,607
| New | +$378K | 0.45% | 23 |
|
|
2017
Q1 | – | Sell |
-28,913
| Closed | -$834K | – | 19 |
|
|
2016
Q4 | $834K | Buy |
28,913
+17,217
| +147% | +$455K | 0.43% | 22 |
|
|
2016
Q3 | $372K | Buy |
+11,696
| New | +$397K | 0.04% | 34 |
|
Other funds holding ACAD
BBA
RI
PAI
JGP Global Gestao de Recursos's ACAD Position: Q2 2026 in Review
JGP Global Gestao de Recursos opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2026: 8,110 shares worth $205K. The stake represents 0.45% of the portfolio and ranks #28 among its holdings. This is a return to the name: JGP Global Gestao de Recursos previously reported a position in ACAD as recently as Q4 2025.
JGP Global Gestao de Recursos first reported a position in ACAD in Q3 2016 and has held it in 34 quarters since. The position peaked at $1.13M in Q4 2023. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.
- JGP Global Gestao de Recursos held 8,110 shares of Acadia Pharmaceuticals worth $205K as of Q2 2026.
- Acadia Pharmaceuticals was a new JGP Global Gestao de Recursos position in Q2 2026.
- Acadia Pharmaceuticals made up 0.45% of JGP Global Gestao de Recursos's portfolio in Q2 2026, its #28 holding.
- JGP Global Gestao de Recursos first reported a position in Acadia Pharmaceuticals in Q3 2016 and has held it in 34 quarters since.
- JGP Global Gestao de Recursos's Acadia Pharmaceuticals position peaked at $1.13M in Q4 2023.
- 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.
Based on JGP Global Gestao de Recursos's 13F filing for Q2 2026, filed 20 Jul 2026.